Business
MedX Health Corp. results for the Second Quarter of fiscal 2013
TSX Venture Symbol: MDX CUSIP #:   585090 MISSISSAUGA, ON, Aug. 27, 2013 ...
About this update from Medx Health Corp.
[{"type":"text","content":"\n\n\nTSX Venture Symbol: MDX\n\n\nCUSIP #:   585090\n\n\nMISSISSAUGA, ON, Aug. 27, 2013 /CNW/ - MedX Health Corp. (\"MDX\" or the\n \"Company\") (TSX-V: MDX) reported today its financial and operational\n results for the Second Quarter of fiscal 2013. All amounts are in\n Canadian dollars unless otherwise stated.\n\n\nSecond Quarter Financial Highlights\n\n\nThe highlights for MDX, on a consolidated basis, are:\n\n\n\nConsolidated revenue increased by 20% to $190,000 in Q2 2013 compared to\n $158,000 in Q2 2012;\n\n\nConsolidated Gross Profit increased 22% to $111,920 in Q2 2013 compared\n to $92,000 in Q2 2012;\n\n\nConsolidated operating expenses decreased by 37% to $287,000 in Q2 2013\n compared to $458,000 in Q2 2012;\n\n\n52% decrease in consolidated net loss before income taxes to a loss of\n $175,000 in Q2 2013 compared to net loss of $365,000 in Q2 2012;\n\n\n\nSteven Guillen, CEO, said:  \"The Second Quarter of Fiscal 2013 continued\n to present many challenges while we were in the process of changing\n many aspects of our business strategy.  We have significantly developed\n and re-aligned our strategic approach to marketing which we believe\n will lead to major developments during the latter part of fiscal 2013\n as we bring our products, especially the MoleMate™ units, to the market\n through new channels.\"\n\n\nA summary of the Results for the Second Quarters of fiscal 2013 and 2012\n (in thousands of dollars, except per share earnings) is included in the\n Table below:\n\n\n\n\n\n\n\n \n\n\n2013 - Q2\n\n\n2012 - Q2\n\n\n\n\nRevenues\n\n\n190\n\n\n158\n\n\n\n\nCost of goods sold\n\n\n78\n\n\n65\n\n\n\n\nGross profit (loss)\n\n\n112\n\n\n93\n\n\n\n\nComprehensive loss\n\n\n(175)\n\n\n(365)\n\n\n\n\nPer share\n\n\n(0.01)\n\n\n(0.01)\n\n\n\n\nTotal assets\n\n\n469\n\n\n681\n\n\n\n\n\n\n\nConsolidated Unaudited Interim Financial Statements\n\n\nNOTE TO READER: The following unaudited interim financial statements are extracted from\n the complete unaudited interim financial statements of the Company for\n the Three and Six Months ended June 30, 2013, which have been filed on\n SEDAR together with the Management's Discussion and Analysis.\n References to \"accompanying Notes\" refer to the Notes to the unaudited\n interim financial statements for the Three and Six Months ended June\n 30, ...